Adamis Pharmaceuticals Corp. | Mutual Funds
Mutual Funds that own Adamis Pharmaceuticals Corp.
Vanguard Total Stock Market Index Fund
782,045
1.65%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
404,838
0.86%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
122,410
0.26%
0
0%
07/31/2018
iShares Micro Cap ETF
86,089
0.18%
0
0.02%
09/06/2018
T Rowe Price Extended Equity Market Index Fund
69,800
0.15%
0
0.02%
06/30/2018
Vanguard Institutional Total Stock Market Index Fund
51,619
0.11%
0
0%
07/31/2018
Fidelity Spartan Total Market Index Fund
48,966
0.1%
0
0%
07/31/2018
DFA US Small Cap Portfolio
45,852
0.1%
45,852
0%
04/30/2018
Vanguard Balanced Index Fund
32,500
0.07%
0
0%
07/31/2018
Northern Small Cap Core Fund
31,122
0.07%
23,462
0.02%
03/31/2018
| Address |
11682 El Camino Real
San Diego California 92130
United States
|
|
Employees
|
- |
| Website |
http://www.adamispharmaceuticals.com |
| Updated |
07/08/2019 |
| Adamis Pharmaceuticals Corp. is a biopharmaceutical company which is focused on developing and commercializing products in the therapeutic areas of respiratory disease and allergy. . Its activities include the combination of pharmaceuticals and biotechnology to produce medicines for patients, and physicians. |
